Literature DB >> 18032510

Gag-processing defect of human immunodeficiency virus type 1 integrase E246 and G247 mutants is caused by activation of an overlapping 5' splice site.

Dibyakanti Mandal1, Zehua Feng, C Martin Stoltzfus.   

Abstract

We have previously described several human immunodeficiency virus type 1 (HIV-1) mutants that are characterized by an excessive-RNA-splicing phenotype and reduced virus particle production. In one of these mutants (NLD2up), the sequence of 5' splice site D2 was changed to a consensus splice donor site. This splice site overlaps the HIV-1 integrase reading frame, and thus, the NLD2up mutant also bears a G-to-W change at amino acid 247 of the integrase. A previously described E-to-K mutant at position 246 of the C-terminal domain of the integrase, which resulted in a G-to-A mutation at the +3 position of overlapping splice donor D2 (NLD2A3), was also shown to affect virus particle production and Gag protein processing. By using second-site mutations to revert the excessive-splicing phenotype, we show that the effects on Gag protein processing and virus particle production of both the NLD2up and NLD2A3 mutants are caused by excessive viral RNA splicing due to the activation of the overlapping 5' splice site and not to the changes in the integrase protein. Both integrase protein mutations, however, are lethal for virus infectivity. These studies suggest that changes in the usage of overlapping splice sites may be a possible alternative explanation for a defective virus phenotype resulting from changes in protein-coding sequences or in the nucleotide sequence during codon optimization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032510      PMCID: PMC2224444          DOI: 10.1128/JVI.02295-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  High level expression of human immunodeficiency virus type-1 Vif inhibits viral infectivity by modulating proteolytic processing of the Gag precursor at the p2/nucleocapsid processing site.

Authors:  Hirofumi Akari; Mikako Fujita; Sandra Kao; Mohammad A Khan; Miranda Shehu-Xhilaga; Akio Adachi; Klaus Strebel
Journal:  J Biol Chem       Date:  2004-01-13       Impact factor: 5.157

2.  U1 snRNP targets an essential splicing factor, U2AF65, to the 3' splice site by a network of interactions spanning the exon.

Authors:  B E Hoffman; P J Grabowski
Journal:  Genes Dev       Date:  1992-12       Impact factor: 11.361

3.  Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus.

Authors:  A Aldovini; R A Young
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

4.  Exon definition may facilitate splice site selection in RNAs with multiple exons.

Authors:  B L Robberson; G J Cote; S M Berget
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

5.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

6.  Human GC-AG alternative intron isoforms with weak donor sites show enhanced consensus at acceptor exon positions.

Authors:  T A Thanaraj; F Clark
Journal:  Nucleic Acids Res       Date:  2001-06-15       Impact factor: 16.971

7.  LuSIV cells: a reporter cell line for the detection and quantitation of a single cycle of HIV and SIV replication.

Authors:  J W Roos; M F Maughan; Z Liao; J E Hildreth; J E Clements
Journal:  Virology       Date:  2000-08-01       Impact factor: 3.616

8.  Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions.

Authors:  A Lever; H Gottlinger; W Haseltine; J Sodroski
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

9.  In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity.

Authors:  R L Willey; D H Smith; L A Lasky; T S Theodore; P L Earl; B Moss; D J Capon; M A Martin
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

10.  A suboptimal 5' splice site downstream of HIV-1 splice site A1 is required for unspliced viral mRNA accumulation and efficient virus replication.

Authors:  Joshua M Madsen; C Martin Stoltzfus
Journal:  Retrovirology       Date:  2006-02-03       Impact factor: 4.602

View more
  14 in total

1.  Excessive RNA splicing and inhibition of HIV-1 replication induced by modified U1 small nuclear RNAs.

Authors:  Dibyakanti Mandal; Zehua Feng; C Martin Stoltzfus
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

Review 2.  Transcriptional and posttranscriptional regulation of HIV-1 gene expression.

Authors:  Jonathan Karn; C Martin Stoltzfus
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

3.  Interaction between Reverse Transcriptase and Integrase Is Required for Reverse Transcription during HIV-1 Replication.

Authors:  Shewit S Tekeste; Thomas A Wilkinson; Ethan M Weiner; Xiaowen Xu; Jennifer T Miller; Stuart F J Le Grice; Robert T Clubb; Samson A Chow
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

4.  NKNK: a New Essential Motif in the C-Terminal Domain of HIV-1 Group M Integrases.

Authors:  Marine Kanja; Pierre Cappy; Nicolas Levy; Oyndamola Oladosu; Sylvie Schmidt; Paola Rossolillo; Flore Winter; Romain Gasser; Christiane Moog; Marc Ruff; Matteo Negroni; Daniela Lener
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

5.  Regulation of Vif mRNA splicing by human immunodeficiency virus type 1 requires 5' splice site D2 and an exonic splicing enhancer to counteract cellular restriction factor APOBEC3G.

Authors:  Dibyakanti Mandal; Colin M Exline; Zehua Feng; C Martin Stoltzfus
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

6.  Negative and positive mRNA splicing elements act competitively to regulate human immunodeficiency virus type 1 vif gene expression.

Authors:  C M Exline; Z Feng; C M Stoltzfus
Journal:  J Virol       Date:  2008-02-13       Impact factor: 5.103

7.  Natural single-nucleotide polymorphisms in the 3' region of the HIV-1 pol gene modulate viral replication ability.

Authors:  Masako Nomaguchi; Ariko Miyake; Naoya Doi; Sachi Fujiwara; Yasuyuki Miyazaki; Yasuko Tsunetsugu-Yokota; Masaru Yokoyama; Hironori Sato; Takao Masuda; Akio Adachi
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

8.  Digoxin suppresses HIV-1 replication by altering viral RNA processing.

Authors:  Raymond W Wong; Ahalya Balachandran; Mario A Ostrowski; Alan Cochrane
Journal:  PLoS Pathog       Date:  2013-03-28       Impact factor: 6.823

9.  Characterization of novel inhibitors of HIV-1 replication that function via alteration of viral RNA processing and rev function.

Authors:  Raymond W Wong; Ahalya Balachandran; Matthew Haaland; Peter Stoilov; Alan Cochrane
Journal:  Nucleic Acids Res       Date:  2013-08-13       Impact factor: 16.971

10.  A functional conserved intronic G run in HIV-1 intron 3 is critical to counteract APOBEC3G-mediated host restriction.

Authors:  Marek Widera; Frank Hillebrand; Steffen Erkelenz; Ananda Ayyappan Jaguva Vasudevan; Carsten Münk; Heiner Schaal
Journal:  Retrovirology       Date:  2014-08-29       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.